T45.1X2
Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code T45.1X2 describes cases where individuals intentionally harm themselves by poisoning with antineoplastic and immunosuppressive drugs. These medications are typically used to treat cancer and prevent rejection of organ transplants, but in this context, they are misused intentionally, which can lead to serious health consequences. Recognizing the implications of this diagnosis is important for healthcare providers and caregivers in supporting affected individuals.
Causes & Symptoms
Clinical Causes: Intentional self-harm or suicide attempts involving antineoplastic or immunosuppressive medications. Underlying mental health conditions such as depression, anxiety, or substance abuse disorders that increase the risk of self-injury. Poor access to mental health care or lack of adequate support networks. Misuse of prescribed medications or diversion from legitimate medical use. Previous history of self-harm or suicidal ideation.
Key Symptoms: Nausea and vomiting Severe abdominal pain Dizziness or lightheadedness Weakness or fatigue Convulsions or seizures Altered mental status, confusion, or decreased consciousness Rapid heartbeat or irregular heartbeat Signs of multi-organ failure in severe cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis begins with a comprehensive medical assessment, including a detailed history of medication exposure and intent. Blood tests often reveal elevated drug levels or metabolites of antineoplastic and immunosuppressive drugs. Additional laboratory tests to evaluate organ function, such as liver and kidney panels, are important. Healthcare providers may also perform toxicology screens to identify other substances involved. Mental health evaluations are essential to understand the underlying intent and to determine necessary psychological support.
Treatment Protocols: Treatment for poisoning by antineoplastic and immunosuppressive drugs due to self-harm involves immediate medical intervention to stabilize the patient. Approaches include:
Clinical Advice & FAQs
Billing Guidance
Is T45.1X2 a billable ICD-10 code?
Yes, T45.1X2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T45.1X2?
Clinical documentation must specify the nature of Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm and any associated comorbidities for accurate reporting.
Cite this Clinical Reference